Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin - Takeaways - MDSpire

Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin

  • By

  • Makoto Harada

  • Jonathan Adam

  • Siyu Han

  • Mengya Shi

  • Jianhong Ge

  • Jutta Lintelmann

  • Alexander Cecil

  • Sven Zukunft

  • Cornelia Prehn

  • Michael Witting

  • Markus F. Scheerer

  • Susanne Neschen

  • Martin Irmler

  • Johannes Beckers

  • Jerzy Adamski

  • Daniel Teupser

  • Birgit Linkohr

  • Christian Gieger

  • Martin Hrabě de Angelis

  • Annette Peters

  • Rui Wang-Sattler

  • January 8, 2026

  • 0 min

Share

  • 1

    Type 2 diabetes management requires optimal glycemic control and pharmacological interventions, with metformin as the first-line therapy.

  • 2

    SGLT2 inhibitors, used as add-on therapy, provide cardio-renal protection and additional tissue-protective effects.

  • 3

    Targeted metabolomics is essential for understanding the metabolic effects of combined SGLT2 inhibitors and metformin therapy.

  • 4

    The study analyzed serum samples from T2D patients and db/db mice to evaluate the metabolic effects of combination therapy.

  • 5

    Findings suggest that combination therapy mitigates adverse effects and modulates the urea cycle, enhancing systemic benefits.

Original Source(s)

Modulation of the Urea Cycle through the Combined Use of SGLT2 Inhibitors and Metformin

  • by Makoto Harada, Jonathan Adam, Siyu Han, Mengya Shi, Jianhong Ge, Jutta Lintelmann, Alexander Cecil, Sven Zukunft, Cornelia Prehn, Michael Witting, Markus F. Scheerer, Susanne Neschen, Martin Irmler, Johannes Beckers, Jerzy Adamski, Daniel Teupser, Birgit Linkohr, Christian Gieger, Martin Hrabě de Angelis, Annette Peters, Rui Wang-Sattler

  • January 8, 2026

Related Content

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

Suprachoroidal Injection in the Treatment of Diabetic Macular Edema: Mechanisms, Clinical Advances, and Future Perspectives

Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts